Emmaus Life Sciences (EMMA)
(Delayed Data from OTC)
$0.07 USD
0.00 (0.00%)
Updated Jul 16, 2024 11:05 AM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
EMMA 0.07 0.00(0.00%)
Will EMMA be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for EMMA based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for EMMA
Emmaus Life Sciences names Willis Lee as CEO
Emmaus Life Sciences Announces Willis C. Lee as Chief Executive Officer
Emmaus Life Sciences appoints Willis Lee as CEO
Emmaus Life Sciences Announces Outcome of FDA Inspection of Postmarketing Adverse Drug Experience Compliance Program
Emmaus Life Sciences Reports 2023 Financial Results